NCT06083974View on ClinicalTrials.gov

Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy

CompletedOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2015

Primary Completion Date

December 30, 2022

Study Completion Date

December 30, 2022

Conditions
Metastatic Colorectal Adenocarcinoma
All Listed Sponsors
lead

Assiut University

OTHER

NCT06083974 - Metastatic Left Colon and Rectal Cancer Treatment With Anti_EGFR Targeted Therapy | Biotech Hunter | Biotech Hunter